Tsurumi H - Search Results

1

Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens.

Goto N, Tsurumi H, Goto H, Shimomura YI, Kasahara S, Hara T, Yasuda I, Shimizu M, Murakami N, Yoshikawa T, Fukuno K, Takahashi T, Kito Y, Takami T, Moriwaki H. Goto N, et al. Among authors: tsurumi h. Ann Hematol. 2012 May;91(5):705-714. doi: 10.1007/s00277-011-1363-4. Epub 2011 Dec 21. Ann Hematol. 2012. PMID: 22183251

2

[Flow cytometric determination of active oxygen produced by neutrophils in patients with inflammatory diseases].

Tsurumi H, Shimazaki M, Takemura M, Shimizu N, Moriwaki H, Muto Y, Shimokawa K, Noma A. Tsurumi H, et al. Rinsho Byori. 1992 Oct;40(10):1080-4. Rinsho Byori. 1992. PMID: 1307612 Japanese.

3

CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.

Tsurumi H, Takahashi T, Moriwaki H, Muto Y. Tsurumi H, et al. Int J Hematol. 1992 Aug;56(1):99-102. Int J Hematol. 1992. PMID: 1327272

4

Congenital combined deficiency of factor V and factor VIII with acquired ichthyosis, epidermodysplasia verruciformis, and immunological abnormalities.

Tsurumi H, Takahashi T, Moriwaki H, Muto Y. Tsurumi H, et al. Am J Hematol. 1992 Aug;40(4):320-1. doi: 10.1002/ajh.2830400420. Am J Hematol. 1992. PMID: 1503092 No abstract available.

5

[Acute megakaryoblastic leukemia with leukemia cutis, meningeal leukemia, and myelofibrosis].

Tsurumi H, Takahashi T, Koshino Y, Oyama M, Matsutomo K, Yasuda M, Moriwaki H, Muto Y. Tsurumi H, et al. Rinsho Ketsueki. 1991 Nov;32(11):1475-80. Rinsho Ketsueki. 1991. PMID: 1758056 Japanese.

6

A case of leiomyoblastoma (epithelioid leiomyosarcoma) of the greater omentum.

Tsurumi H, Okada S, Koshino Y, Oyama M, Higaki H, Shimokawa K, Yamauchi O, Moriwaki H, Muto Y. Tsurumi H, et al. Gastroenterol Jpn. 1991 Jun;26(3):370-5. doi: 10.1007/BF02781927. Gastroenterol Jpn. 1991. PMID: 1832406

7

The combined effects of all-trans retinoic acid and granulocyte colony-stimulating factor as a differentiation induction therapy for acute promyelocytic leukemia.

Tsurumi H, Tojo A, Takahashi T, Moriwaki H, Asano S, Muto Y. Tsurumi H, et al. Intern Med. 1993 Aug;32(8):648-50. doi: 10.2169/internalmedicine.32.648. Intern Med. 1993. PMID: 7508772 Free article.

8

[Treatment of acute promyelocytic leukemia--combined use of all-trans retinoic acid and granulocyte colony-stimulating factor].

Tsurumi H, Yamada T, Sawada M, Nakamura N, Takahashi T, Moriwaki H, Muto Y. Tsurumi H, et al. Rinsho Ketsueki. 1995 Jun;36(6):582-8. Rinsho Ketsueki. 1995. PMID: 7543953 Clinical Trial. Japanese.

9

[Continuous infusion therapy with low dose cytosine arabinoside and etoposide in acute myelogenous leukemia patients hardly tolerable for intensive combination chemotherapy].

Tsurumi H, Miura T, Yamada T, Sawada M, Nakamura N, Tomoda T, Takahashi T, Oyama M, Moriwaki H, Muto Y. Tsurumi H, et al. Rinsho Ketsueki. 1995 Jul;36(7):657-64. Rinsho Ketsueki. 1995. PMID: 7563593 Clinical Trial. Japanese.

10

Differentiation induction of human promyelocytic leukemia cells by acyclic retinoid (polyprenoic acid).

Tsurumi H, Tojo A, Takahashi T, Ozawa K, Moriwaki H, Asano S, Muto Y. Tsurumi H, et al. Int J Hematol. 1993 Dec;59(1):9-15. Int J Hematol. 1993. PMID: 8161738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters